In this week's episode of The Crypto Craze Cheddar Anchors Brad Smith and Baker Machado explain the biggest trends in the market. This week the value of Bitcoin plunged to just 50 percent of its 2017 peak. Several other cryptocurrencies saw double digit losses compared to their highs last year. Many citing the potential crackdown on regulation in South Korea and China as a trigger of this volatility.
Venture firm Full Tilt Capital is making the move to only invest in tokenized securities. The firm's Managing Partner Anthony Pompliano explains the investment opportunity he sees in this space.
"There's going to be a bunch of scams, there's going to be a lot of people that are going to get caught up in the tightening of regulation, but we are also going to get a lot of sustainable technologies that come out of this," says Pompliano. He says he sees the infrastructure, miners, exchanges, and the wallets as being the true winners in this evolving space.
Browser plug-in "Trive" is using the power of blockchain to combat fake new. The company's founder and CEO David Mondrus explains how he is leveraging this technology, and his outlook on the cryptocurrency market.
"We have fact-checkers on the net," says Mondrus. Trive crowdsources the verification of news through blockchain technology.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
